Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies

This study has been completed.
Information provided by (Responsible Party):
Santen Oy Identifier:
First received: February 8, 2011
Last updated: March 12, 2013
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):